SpliSense is currently conducting a Phase IIb trial with its antisense oligonucleotide therapy.

Although most known for its effect on the lungs, cystic fibrosis is a far-reaching condition that affects most of the body’s systems. Cystic fibrosis is a chronic condition that’s primarily associated ...

The company formally handed over its drug, Triko, to cystic fibrosis patients and representatives from six countries ...

Atypical cystic fibrosis is a mild form of cystic fibrosis. People with this type of cystic fibrosis can experience symptoms that come and go or that are less severe than those people with classic ...

Breathing disorders are common in the U.S. with conditions like COPD affecting some 7% of the population and asthma affecting another 10%. Digestive conditions like GERD, acid reflux, Celiac disease ...